Compare CBRE & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBRE | MDLN |
|---|---|---|
| Founded | 1906 | 1966 |
| Country | United States | United States |
| Employees | 44000 | 45000 |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.5B | 37.4B |
| IPO Year | 2001 | N/A |
| Metric | CBRE | MDLN |
|---|---|---|
| Price | $130.33 | $36.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 23 |
| Target Price | ★ $177.86 | $50.48 |
| AVG Volume (30 Days) | 1.7M | ★ 6.1M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.61 | N/A |
| EPS | ★ 1.07 | N/A |
| Revenue | ★ $40,550,000,000.00 | N/A |
| Revenue This Year | $14.31 | $10.88 |
| Revenue Next Year | $9.06 | $7.69 |
| P/E Ratio | ★ $125.03 | $658.75 |
| Revenue Growth | ★ 13.37 | N/A |
| 52 Week Low | $118.81 | $37.65 |
| 52 Week High | $174.27 | $50.88 |
| Indicator | CBRE | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 30.17 | 25.95 |
| Support Level | $127.40 | N/A |
| Resistance Level | $138.73 | $44.89 |
| Average True Range (ATR) | 4.38 | 1.76 |
| MACD | -1.68 | -0.76 |
| Stochastic Oscillator | 16.70 | 0.44 |
CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory. CBRE's investment management arm managed over $155 billion (at year-end 2025) for clients across diverse public and private real estate strategies.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.